# Partially Replicate Bioequivalence Study of Quetiapine 25 mg in Healthy Volunteers Under Fasting Condition

> **NCT05235230** · PHASE1 · COMPLETED · sponsor: **Future University in Egypt** · enrollment: 32 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Test product (T) 25 mg Film Coated Tablets
- **DRUG:** Reference product (R) 25 mg Film Coated Tablets

## Key facts

- **NCT ID:** NCT05235230
- **Lead sponsor:** Future University in Egypt
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-19
- **Primary completion:** 2021-06-03
- **Final completion:** 2021-06-03
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2022-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05235230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05235230, "Partially Replicate Bioequivalence Study of Quetiapine 25 mg in Healthy Volunteers Under Fasting Condition". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05235230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*